Provided by Tiger Trade Technology Pte. Ltd.

Dare Bioscience

0.7478
+0.02233.07%
Post-market: 0.76270.0149+1.99%17:24 EDT
Volume:153.22K
Turnover:115.98K
Market Cap:14.71M
PE:-0.96
High:0.7759
Open:0.7445
Low:0.7445
Close:0.7255
52wk High:3.78
52wk Low:0.6900
Shares:19.67M
Float Shares:17.33M
Volume Ratio:0.88
T/O Rate:0.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7779
EPS(LYR):-1.1986
ROE:-2543.13%
ROA:-39.29%
PB:-26.23
PE(LYR):-0.62

Loading ...

Mar 30, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 08, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Major Issues Report

8-K - Current report
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Major Issues Report

8-K - Current report
Jan 11, 2021

Major Issues Report

8-K - Current report
Jan 06, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 05, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jan 04, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 04, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 23, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Dec 22, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Dec 09, 2020

Major Issues Report

8-K - Current report
Dec 07, 2020

Major Issues Report

8-K - Current report
Nov 18, 2020

Major Issues Report

8-K - Current report
Nov 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]